These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Wiseman LR; Wagstaff AJ; Brogden RN; Bryson HM Drugs; 1995 Jul; 50(1):73-101. PubMed ID: 7588092 [TBL] [Abstract][Full Text] [Related]
5. Carbapenems and monobactams: imipenem, meropenem, and aztreonam. Hellinger WC; Brewer NS Mayo Clin Proc; 1999 Apr; 74(4):420-34. PubMed ID: 10221472 [TBL] [Abstract][Full Text] [Related]
6. [Preclinical evaluation of meropenem, a new parenteral carbapenem]. Edwards JR New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929 [TBL] [Abstract][Full Text] [Related]
7. Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Buckley MM; Brogden RN; Barradell LB; Goa KL Drugs; 1992 Sep; 44(3):408-44. PubMed ID: 1382937 [TBL] [Abstract][Full Text] [Related]
8. Meropenem: a new carbapenem antimicrobial. Pryka RD; Haig GM Ann Pharmacother; 1994 Sep; 28(9):1045-54. PubMed ID: 7803882 [TBL] [Abstract][Full Text] [Related]
9. Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections. Balfour JA; Bryson HM; Brogden RN Drugs; 1996 Jan; 51(1):99-136. PubMed ID: 8741235 [TBL] [Abstract][Full Text] [Related]
10. Meropenem: a review of its use in the treatment of serious bacterial infections. Baldwin CM; Lyseng-Williamson KA; Keam SJ Drugs; 2008; 68(6):803-38. PubMed ID: 18416587 [TBL] [Abstract][Full Text] [Related]
11. [In vitro antibacterial activity of meropenem, a new carbapenem: European data]. Debbia EA; Marchese A; Pesce A; Schito GC New Microbiol; 1995 Oct; 18 Suppl():1S-17S. PubMed ID: 8574928 [TBL] [Abstract][Full Text] [Related]
12. Meropenem: a review of its use in patients in intensive care. Hurst M; Lamb HM Drugs; 2000 Mar; 59(3):653-80. PubMed ID: 10776838 [TBL] [Abstract][Full Text] [Related]
13. [The role of carbapenems in the treatment of nosocomial infection]. Martínez Lacasa J; Garau J Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():78-85. PubMed ID: 9410075 [TBL] [Abstract][Full Text] [Related]
14. Meropenem, a new carbapenem antibiotic. Fish DN; Singletary TJ Pharmacotherapy; 1997; 17(4):644-69. PubMed ID: 9250544 [TBL] [Abstract][Full Text] [Related]
15. Meropenem: an updated review of its use in the management of intra-abdominal infections. Lowe MN; Lamb HM Drugs; 2000 Sep; 60(3):619-46. PubMed ID: 11030471 [TBL] [Abstract][Full Text] [Related]
16. Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit. Verwaest C; Clin Microbiol Infect; 2000 Jun; 6(6):294-302. PubMed ID: 11168137 [TBL] [Abstract][Full Text] [Related]
17. Ertapenem: review of a new carbapenem. Zhanel GG; Johanson C; Embil JM; Noreddin A; Gin A; Vercaigne L; Hoban DJ Expert Rev Anti Infect Ther; 2005 Feb; 3(1):23-39. PubMed ID: 15757455 [TBL] [Abstract][Full Text] [Related]
19. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients. Kuo BI; Fung CP; Liu CY Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445 [TBL] [Abstract][Full Text] [Related]
20. A comparative study of the in vitro activity of meropenem and representatives of the major classes of broad-spectrum antibiotics. Greenhalgh JM; Edwards JR Clin Microbiol Infect; 1997 Feb; 3 Suppl 4():S20-S31. PubMed ID: 11869239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]